Wykład 2 Advanced biostatistical tools
Advanced Biostatistical Tools
Small-area methods: Tools for studying epidemiological risk
Importance of assessing the need for these methods in current health studies.
COVID-19 Dashboard
Global Cases: 48,092,115
Cases by Country/Region/Sovereignty:
US: 9,486,486
India: 8,364,086
Brazil: 5,590,025
Russia: 1,680,579
France: 1,591,152
Spain: 1,284,408
Global Deaths: 1,225,221
US: 233,729 deaths
Brazil: 161,106 deaths
India: 124,315 deaths
Mexico: 93,228 deaths
UK: 47,832 deaths
Italy: 39,764 deaths
Other countries listed with significant death tolls.
US State Level Data:
New York: 33,556 deaths, 80,109 recovered
Texas: 18,771 deaths (recovered numbers missing)
California: 17,820 deaths
Florida: 16,922 deaths, 37,559 recovered
New Jersey: 16,391 deaths (recovered numbers missing)
Dashboard Includes:
Active Cases
Incidence Rate
Case-Fatality Ratio
Testing Rate
Data sourced from various databases including JHU CSSE.
Small-Area Studies
A powerful approach for studying disease patterns in populations.
Evaluates health risks posed by environmental pollutants.
Includes:
Environmental exposures.
Health impacts on populations.
Framework of Small-Area Studies
Public health investigations are conducted on geographical scales (e.g., neighborhoods).
Overlay of health, environmental, demographic, and confounder data is essential.
Key aspects include:
Rapid data linkage from diverse sources for improved analysis.
Utilization in surveillance and prevention of non-communicable diseases.
Methodological Advances in Small-Area Studies
Incorporation of Bayesian approaches.
Enhanced computational capabilities facilitating more informative analyses.
Complexity and Challenges
Increased complexity in design includes:
Choice of optimal study area size.
Duration of the study.
Range of covariates/confounders considered.
Managing uncertainty in data.
Requirement of Data Availability
Small-area studies rely heavily on the availability of:
Health data
Environmental data
Demographic data
Confounder data
Focuses on entire populations or large subsets for validity.
Example of Health Data Utilization
Neighbourhood data example: deprivation and environmental exposures.
Longitudinal studies linking participants to residential address and health data.
Benefits of Small-Area Studies
Factors to consider:
Approximate individual-level risks when individual data is scarce.
Investigate health risks from environmental pollution.
Detect high-risk areas for interventions.
Conduct investigations of disease clusters.
Health Data Accessibility
Access to health records has greatly improved over the last 2-3 decades.
Example from England:
100 million records added annually in NHS.
The Small Area Health Statistics Unit (SAHSU) maintains a comprehensive database with over 600 million health records.
Geographical Data Analysis
Caveat: Population data may show disparities, especially in rural low/middle-income countries.
Importance of population-based cancer registries as data sources.
Addressing Confounder Data
Small-area studies require attention to confounding factors to validate findings.
Must standardize data across demographics (age and gender).
Spatial Epidemiology Concepts
Spatial epidemiology involves examining geographic variations in disease concerning various risk factors:
Demographic
Environmental
Socioeconomic
Genetic
Behavioral
Disease Mapping
Visual representation aids in identifying the geographical distribution of disease.
Historical example: John Snow's cholera mapping in London (1854).
Smoothing Techniques in Data Analysis
Statistical smoothing aids in reducing variability across geographical data.
Allows for more accurate readings but can potential mask risks in less populated areas.
Uncovering Disease Clustering
Clustering analysis focuses on identifying unusual case accumulations within a population.
Requires distinguishing between general and specific clustering approaches.
Application of Small Area Techniques to COVID-19
Small Area Estimation models assess:
Disease incidence and prevalence.
Social distancing impact.
COVID-19 related mortality.
Summary of COVID-19 Data Across Regions
Comparative analysis of cases per 100,000 residents across multiple European regions.
Current Healthcare Applications
Highlight examples:
Risks from aspirin usage in relation to COVID-19 outcomes.